Landmark moment for treatment of advanced breast cancer
Автор: The Institute of Cancer Research, London
Загружено: 2022-12-08
Просмотров: 4956
Описание:
A new targeted drug has shown 'remarkable' benefits for patients with advanced breast cancer in a major phase III clinical trial.
The drug, capivasertib combined with hormone therapy doubled the time it took for cancer to progress in people with advanced forms of ER-positive, HER-2 negative breast cancer - the most common type of breast cancer.
See our website to find out more about the trial and the ICR's involvement in the discovery of capivasertib: https://www.icr.ac.uk/news-archive/ne...
Повторяем попытку...
Доступные форматы для скачивания:
Скачать видео
-
Информация по загрузке: